$SCM Balance Sheet | Understand Stock

$SCM

$6.72 +$0.08 (1.2%) Close

$SCM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of assets and liabilities

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022
ASSETS
Fair value of investments
Controlled investments
Non-controlled/affiliated
Non-controlled/Unaffiliated
Total fair value of investments
Cash and cash equivalents
Receivable for sales and repayments of investments
Interest receivable
Income tax receivable
Other receivables
Related Party
Related party
Nonrelated party
Total other receivables

Related party receivable
Deferred offering costs
Prepaid expenses
Total Assets

LIABILITIES
2030 Notes Payable
Credit Facility payable
SBA-guaranteed debentures
Dividends payable
Management fees payable
Income incentive fees payable
Capital gains incentive fees payable
Interest payable
Related party payable
Related party
Nonrelated party
Total related party payable

Unearned revenue
Deferred tax liability
Administrative services payable
Income tax payable
Other accrued expenses and liabilities
Total Liabilities
Net Assets
Total Liabilities and Net Assets
Net Asset Value Per Share

NET ASSETS
Common stock, par value $0.001 per share (100,000,000 shares authorized; 28,672,911 and 28,947,254 shares issued and outstanding, respectively)
Paid-in capital
Total distributable loss

Comments